Presidio Pharmaceuticals presidiopharma.com


Public lists: Pharma Startups (4732)

Presidio Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics. Presidio's focus is on effective therapies for hepatitis C virus (HCV) infection. With a pipeline consisting of compounds targeting both the NS5A and NS5B proteins of HCV, Presidio is positioned to compete in the growing HCV therapy market. Presidio's goal is to discover and advance small-molecule, antiviral drug candidates that are potent, have...Show all

Presidio Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to the discovery and development of small-molecule antiviral therapeutics. Presidio's focus is on effective therapies for hepatitis C virus (HCV) infection. With a pipeline...Show all

Company (Alive / Active)

Phone: 415-655-7560

Fax:

1700 Owens Street
Suite 585
San Francisco, 94158
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Presidio Pharmaceuticals $94.1M Feb 26, 2018
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Presidio Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Competitors

Company Status Description Investors

OptiMedica

Sunnyvale, California, United States
AcquiredOptiMedica is a global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. Exclusively focused in the cataract therapeutic area, the company has developed the Catalys Precision Laser System to transform existing standards of care in cataract surgery. The company has also developed and commercialized the PASCAL Method of retinal photocoagulation, which was acquired by Topcon Corp. in August 2010. In August 2013, OptiMedica was acquired...Show allLogin to see details

Arete Therapeutics

Hayward, California, United States
Dead / InactiveArete Therapeutics Inc. is a privately-held pharmaceutical company discovering and developing first-in-class small molecule drugs directed at soluble epoxide hydrolase (s-EH), a unique enzyme which plays a key role in the arachidonic acid pathway. Arete has discovered and developed a series of proprietary and chemically diverse molecules with preclinical efficacy in various animal models, and is conducting a phase 1 clinical trial with its first-in-class compound, AR9281. The company has raised ...Show allLogin to see details
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Inhibitors of hepatitis c virus Nov 18, 2013 Apr 12, 2016 Patent
Inhibitors of hcv ns5a Dec 02, 2009 Sep 01, 2015 Patent
Inhibitors of hepatitis c virus Apr 25, 2012 Jul 21, 2015 Patent
Tricyclic fused ring inhibitors of hepatitis c Sep 28, 2011 Apr 07, 2015 Patent
Inhibitors of hcv ns5a Dec 02, 2009 Dec 30, 2014 Patent
See all 14 patents